Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Imunon Inc IMNN

Healthcare Biotechnology
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. The Company is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment... see more

Recent & Breaking News (NDAQ:IMNN)

Celsion to Present at Three Investment Conferences in October

GlobeNewswire September 30, 2021

Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsion's DNA-based Vaccine

GlobeNewswire September 17, 2021

Celsion Reports T-cell and B-cell Response from In Vivo Studies with its PLACCINE DNA Vaccine Platform

GlobeNewswire September 2, 2021

Celsion to Host Research and Development Update October 12, 2017

GlobeNewswire October 4, 2017

Celsion Provides Update on ThermoDox® in the Phase III OPTIMA Study of Primary Liver Cancer

GlobeNewswire September 27, 2017

Celsion Announces Presentation of OVATION Study Findings at the Upcoming AACR Special Conference

GlobeNewswire August 24, 2017

Stocks Under Scanner in the Biotech Space -- Merrimack Pharma, MannKind, NeuroDerm, and Celsion

PR Newswire August 23, 2017

Celsion Corporation Reports Second Quarter 2017 Financial Results and Provides Business Update

GlobeNewswire August 15, 2017

Investor Network: Celsion Corporation to Host Earnings Call

Accesswire August 15, 2017

Celsion Corporation to Hold Second Quarter 2017 Financial Results Conference Call on Tuesday, August 15, 2017

GlobeNewswire August 8, 2017

Data Monitoring Committee Completes Mid-Study Review of Celsion’s Phase III ThermoDox® OPTIMA Study in Primary Liver Cancer

GlobeNewswire August 7, 2017

Celsion Corporation to Delist from the Tel Aviv Stock Exchange

GlobeNewswire August 4, 2017

Celsion Announces Latest Translational Data from the OVATION Study in Newly Diagnosed Advanced Ovarian Cancer Patients

GlobeNewswire August 2, 2017

15 Biggest Mid-Day Losers For Thursday

Benzinga.com  July 6, 2017

Mid-Day Market Update: Crude Oil Up Over 2%; Egalet Shares Plummet

Benzinga.com  July 6, 2017

Mid-Morning Market Update: Markets Open Lower; Liberty Interactive To Acquire HSN

Benzinga.com  July 6, 2017

Celsion Corporation Announces $5 Million Registered Direct Offering

GlobeNewswire July 6, 2017

Mid-Afternoon Market Update: Crude Oil Down 3.8%; Monogram Residential Trust Shares Spike Higher

Benzinga.com  July 5, 2017

12 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  July 5, 2017

Mid-Day Market Update: NASDAQ Turns Positive; O'Reilly Shares Drop Following Disappointing Comparable Store Sales

Benzinga.com  July 5, 2017